ALFA Filings
Every announcement, straight from the exchange
Every Fredun Pharmaceuticals capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Fredun Pharmaceuticals allotted 1,82,400 equity shares upon the conversion of 60,800 warrants. The company received total consideration of ₹7.60 Crore for this warrant conversion.
Fredun Pharmaceuticals has allotted 1,82,400 equity shares following the conversion of 60,800 warrants into equity shares, completing the preferential issue conversion process.
Fredun Pharmaceuticals allotted 3,61,599 equity shares following the conversion of 1,20,533 warrants. This allotment was executed at an issue price of Rs. 1,250 per warrant.
Fredun Pharmaceuticals allotted 1.10 crore bonus shares in a 2:1 ratio. Post-issue paid-up capital increased to Rs 16.54 crore from Rs 5.51 crore.